Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganmao Jiedu Keli
- Development stage
- Unknown
- Lead developer
- Henan Bainian Kangxin Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Ganmao Jiedu Keli is a traditional Chinese medicine (TCM) oral granule marketed by Henan Bainian Kangxin Pharmaceutical for the treatment of symptoms associated with the common cold and upper respiratory tract infections. As a TCM formulation, it is typically used to clear heat, detoxify the body, and relieve exterior symptoms such as fever, headache, cough, and sore throat. The product is currently approved and available on the market in China, where it is distributed through franchise channels by Henan Bainian Kangxin Pharmaceutical.
- Other names
- 感冒解毒颗粒Ganmao Jiedu GranulesCold-Detoxifying Granules
Beyond the preview
Go deeper on Ganmao Jiedu Keli.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ganmao Jiedu Keli.